Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03261089Recruiting

Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst

Role: collaborator

NCT04415086Phase 2Completed

Treatment of Patients With COVID-19 With Convalescent Plasma

Role: collaborator

NCT00350766Phase 2Terminated

Cell Therapy in Myocardial Infarction

Role: collaborator

NCT01784432Not ApplicableCompleted

Effects of Low-level Laser Therapy on Global Gene Expression of Young Males Submitted to Physical Strength Training

Role: collaborator

NCT01131650Completed

Prevalence of Diabetic Retinopathy in São José do Rio Preto-SP-Brazil

Role: collaborator

All 5 trials loaded